Literature DB >> 33779922

Extracellular Vesicle-Mediated Bone Remodeling and Bone Metastasis: Implications in Prostate Cancer.

Kalyani C Patil1, Carolina Soekmadji2,3.   

Abstract

Bone metastasis is the tendency of certain primary tumors to spawn and dictate secondary neoplasia in the bone. The process of bone metastasis is regulated by the dynamic crosstalk between metastatic cancer cells, cellular components of the bone marrow microenvironment (osteoblasts, osteoclasts, and osteocytes), and the bone matrix. The feed-forward loop mechanisms governs the co-option of homeostatic bone remodeling by cancer cells in bone. Recent developments have highlighted the discovery of extracellular vesicles (EVs) and their diverse roles in distant outgrowths. Several studies have implicated EV-mediated interactions between cancer cells and the bone microenvironment in synergistically promoting pathological skeletal metabolism in the metastatic site. Nevertheless, the potential role that EVs serve in arbitrating intricate sequences of coordinated events within the bone microenvironment remains an emerging field. In this chapter, we review the role of cellular participants and molecular mechanisms in regulating normal bone physiology and explore the progress of current research into bone-derived EVs in directly triggering and coordinating the processes of physiological bone remodeling. In view of the emerging role of EVs in interorgan crosstalk, this review also highlights the multiple systemic pathophysiological processes orchestrated by the EVs to direct organotropism in bone in prostate cancer. Given the deleterious consequences of bone metastasis and its clinical importance, in-depth knowledge of the multifarious role of EVs in distant organ metastasis is expected to open new possibilities for prognostic evaluation and therapeutic intervention for advanced bone metastatic prostate cancer.

Entities:  

Keywords:  Bone metastasis; Bone remodeling; Extracellular vesicles; Prostate cancer

Mesh:

Year:  2021        PMID: 33779922     DOI: 10.1007/978-3-030-67171-6_12

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  250 in total

1.  Understanding coupling between bone resorption and formation: are reversal cells the missing link?

Authors:  Thomas L Andersen; Mohamed E Abdelgawad; Helene B Kristensen; Ellen M Hauge; Lars Rolighed; Jens Bollerslev; Per Kjærsgaard-Andersen; Jean-Marie Delaisse
Journal:  Am J Pathol       Date:  2013-06-06       Impact factor: 4.307

2.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines.

Authors:  A Angelucci; S D'Ascenzo; C Festuccia; G L Gravina; M Bologna; V Dolo; A Pavan
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells.

Authors:  Marc A Antonyak; Bo Li; Lindsey K Boroughs; Jared L Johnson; Joseph E Druso; Kirsten L Bryant; David A Holowka; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

4.  Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.

Authors:  Mona Alsulaiman; Manish V Bais; Philip C Trackman
Journal:  J Cell Commun Signal       Date:  2015-12-01       Impact factor: 5.782

5.  Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.

Authors:  P Ammann; R Rizzoli; J P Bonjour; S Bourrin; J M Meyer; P Vassalli; I Garcia
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Solitary radial head metastasis with wrist drop: a rare presentation of metastatic prostate cancer.

Authors:  M S Ansari; G Nabi; M Aron
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

7.  A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.

Authors:  Thomas L Andersen; Maria del Carmen Ovejero; Tove Kirkegaard; Thomas Lenhard; Niels T Foged; Jean-Marie Delaissé
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

8.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

9.  Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip.

Authors:  Aref Agheli; Yelena Patsiornik; Yu Chen; M Rashid Chaudhry; Howard Gerber; Jen C Wang
Journal:  Radiol Case Rep       Date:  2015-11-06

10.  Synchronous Bone Metastasis From Multiple Myeloma and Prostate Adenocarcinoma as Initial Presentation of Coexistent Malignancies.

Authors:  Diego Andres Adrianzen Herrera; Shlomit Goldberg-Stein; Alexander Sankin; Judy Sarungbam; Janaki Sharma; Benjamin A Gartrell
Journal:  Front Oncol       Date:  2018-04-30       Impact factor: 6.244

View more
  1 in total

Review 1.  Extracellular vesicles in the development of organ-specific metastasis.

Authors:  Fumihiko Urabe; Kalyani Patil; Grant A Ramm; Takahiro Ochiya; Carolina Soekmadji
Journal:  J Extracell Vesicles       Date:  2021-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.